If I’d invested £1,000 in Aviva shares a year ago, here’s what I’d have now

Aviva shares have surged along with their peers on expectations that interest rates will fall. Dr James Fox takes a closer look at the stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Young Caucasian man making doubtful face at camera

Image source: Getty Images

Aviva (LSE:AV) shares are popular with dividend investors. The insurance company has a strong dividend yield — 7.2% — and payments are supported by strong cash flows.

However, if I’d invested in Aviva shares a year ago, I’d be down 2.4%. That’s despite the company surging over the past three months.

So, a £1,000 investment would be worth £976 today. Thankfully I’d have received something in the region of £70 in the form of dividend payments.

What’s been going on?

After peaking in early 2023, the Aviva share price pushed down over the months to September. Aviva’s results during the period were positive but not exceptional.

One reason the stock fell was the fallout from the Silicon Valley Bank crash — which resulted in a major slump in the share price. The crash highlighted to many investors that financial institutions were sitting on billions of dollars of unrealised losses in the form of low coupon bonds.

However, the reality is most financial institutions — the well-managed ones at least — don’t need to sell these bonds. So, they remain unrealised losses.

Nonetheless, this event, and the continued upward movement of interest rates put further downward pressure on Aviva.

There are several ways interest rates impact share prices. The simplest is that when interest rates are rising, and capital moves away from shares and to debt and cash.

So, as expectations of interest rates cuts have risen, capital has started moving back from debt and cash to shares.

A safe dividend?

Insurers often maintain safe dividends due to their prudent financial management and risk assessment practices.

Insurance companies focus on long-term stability and must have sufficient reserves to cover potential policyholder claims.

It’s also the case that insurance companies have strong cash flows. After all, we tend to pay our insurance companies monthly for their cover.

By comparison, drugs companies may have to wait years for a new drug to go on sale.

However, this year it does appear that the coverage ratio isn’t too strong — around one. Dividend payments are likely to amount to around 31p, while analysts believe earnings per share will amount to 31.29p.

Nonetheless, earnings are expected to increase to 48.29p over the next two years. I’d still say these dividends are relatively safe.

Better value elsewhere

Aviva is currently trading 12% below its share price target. That’s not a bad sign, but I believe there is better value elsewhere on the FTSE 100 and within insurance. Aviva is currently facing several earnings headwinds in the near term, hence the lower dividend coverage ratio.

Nonetheless, earnings per share should pick up over the coming 24 months, and the industry is still benefitting from positive trends in the form of bulk purchase annuity, among other things.

But my preference is for Legal & General. The sector peer has a stronger dividend yield at 8.3%, a strong dividend coverage ratio, around two times, and is the market leader in bulk purchase annuity.

James Fox has positions in Legal & General Group Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »